$ATRA

1 thesis
bullish 100%neutral 0%bearish 0%
Avg return (1m)
Win rate (1m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ATRASEC Form 4bullish
Long 104,166 shares of ATRA
Bought 104,166 @ $9.60 avg · $999,994 · 2026-09-04

Form 4: Cherry Brian N bought ATRA

Cherry Brian N (Director at Atara Biotherapeutics, Inc.) reported an open-market purchase of 104,166 shares of ATRA at an average $9.60, roughly $999,994, in a Form 4 filed 2026-09-04.

View filing on SEC.gov →

End of results.